...
首页> 外文期刊>Transplantation: Official Journal of the Transplantation Society >Prevention of renal ischemic injury by silencing the expression of renal caspase 3 and caspase 8.
【24h】

Prevention of renal ischemic injury by silencing the expression of renal caspase 3 and caspase 8.

机译:通过沉默肾脏caspase 3和caspase 8的表达来预防肾脏缺血性损伤。

获取原文
获取原文并翻译 | 示例

摘要

BACKGROUND: Apoptotic pathways mediated by caspases play a critical role in renal ischemia-reperfusion injury (IRI). Downregulation of the caspase cascade, using small interfering RNA (siRNA) to silence the expression of caspase 3 and caspase 8, may have substantial therapeutic potential for limiting renal injury. METHODS: IRI was induced in mice by clamping of the renal vein and artery for 25 or 35 min at 37 degrees C. Caspase 3 and caspase 8 (caspase 3/8) siRNA was administrated by hydrodynamic injection. Quantitative polymerase chain reaction (PCR) and immunohistochemistry were used to analyze the gene silencing efficacy, and the therapeutic effects of siRNA were evaluated by renal function analysis, histological examination, and overall survival of mice suffering from IRI. RESULTS: In this study, we have shown, using quantitative PCR, that IRI is associated with increased levels of renal caspase 3/8 mRNA. Mice treated with caspase 3/8 siRNA showed a significant down-regulation in kidney expression of caspase 3/8 at both, transcriptional and protein levels. Kidney function in IRI was protected by siRNA therapy, as levels of blood urea nitrogen and creatinine were significantly reduced in mice treated with siRNA. Histological examination demonstrated that tissue injury caused by IRI was significantly reduced as a result of caspase 3/8 siRNA treatment. Furthermore, survival data showed that more than 70% of mice in siRNA-treated groups survived until the end of the eight-day observation period. CONCLUSION: Herein, we have demonstrated the therapeutic potential of using siRNA to knock down the expression of caspases and prevent acute renal injury.
机译:背景:胱天蛋白酶介导的凋亡途径在肾脏缺血再灌注损伤(IRI)中起关键作用。使用小干扰RNA(siRNA)沉默caspase 3和caspase 8的表达,下调caspase级联反应可能具有限制肾脏损伤的巨大治疗潜力。方法:通过在37摄氏度下将肾静脉和动脉夹闭25或35分钟,在小鼠中诱导IRI。通过流体动力注射施用caspase 3和caspase 8(caspase 3/8)siRNA。定量聚合酶链反应(PCR)和免疫组化分析基因沉默效果,并通过肾功能分析,组织学检查和IRI小鼠的整体存活率评估siRNA的治疗效果。结果:在这项研究中,我们已经显示出,使用定量PCR,IRI与肾脏caspase 3/8 mRNA水平的增加有关。用半胱天冬酶3/8 siRNA处理的小鼠在转录和蛋白质水平均显示肾脏中半胱天冬酶3/8的表达显着下调。 siRNA治疗可保护IRI的肾脏功能,因为用siRNA治疗的小鼠的血尿素氮和肌酐水平显着降低。组织学检查表明,由于caspase 3/8 siRNA处理,IRI引起的组织损伤明显减少。此外,存活数据显示,在siRNA治疗组中,超过70%的小鼠存活到八天观察期结束。结论:在本文中,我们已经证明了使用siRNA敲低半胱氨酸蛋白酶的表达并预防急性肾损伤的治疗潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号